[HTML][HTML] Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Y Cheng, C He, M Wang, X Ma, F Mo, S Yang… - Signal transduction and …, 2019 - nature.com
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …

[PDF][PDF] Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

2019 - scienceopen.com
After the discovery of DNA and the double helix structure, classic genetics has long
assumed that the sequences of DNA determine the phenotypes of cells. DNA is packaged …

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Y Cheng, H Cai, M Wang, X Ma, F Mo… - Signal Transduction …, 2019 - search.proquest.com
After the discovery of DNA and the double helix structure, classic genetics has long
assumed that the sequences of DNA determine the phenotypes of cells. DNA is packaged …

[HTML][HTML] Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Y Cheng, C He, M Wang, X Ma, F Mo… - Signal Transduction …, 2019 - ncbi.nlm.nih.gov
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Y Cheng, C He, M Wang, X Ma, F Mo… - Signal transduction …, 2019 - pubmed.ncbi.nlm.nih.gov
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Y Cheng, C He, M Wang, X Ma, F Mo… - … & Targeted Therapy, 2019 - search.ebscohost.com
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Y Cheng, C He, M Wang, X Ma, F Mo… - Signal Transduction …, 2019 - europepmc.org
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Y Cheng, C He, M Wang, X Ma, F Mo, S Yang, J Han… - 2019 - hero.epa.gov
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Y Cheng, C He, M Wang, X Ma, F Mo, S Yang… - … and Targeted Therapy, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Epigenetic alternations concern heritable yet
reversible changes in histone or DNA modifications that regulate gene activity beyond the …

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Y Cheng, C He, M Wang, X Ma, F Mo… - Signal Transduction …, 2019 - europepmc.org
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …